Wealthcare Advisory Partners’s Johnson & Johnson JNJ Stock Holding History

Wealthcare Advisory Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.65M	Sell	37,978 -2,946	-7%	-$687K	0.18%	111
2026 Q1	$10M	Sell	40,924 -34,256	-46%	-$7.98M	0.19%	107
2025 Q4	$15.6M	Buy	75,180 +2,890	+4%	+$571K	0.31%	72
2025 Q3	$13.4M	Buy	72,290 +838	+1%	+$144K	0.28%	73
2025 Q2	$10.9M	Buy	71,452 +396	+0.6%	+$60.9K	0.25%	81
2025 Q1	$11.8M	Sell	71,056 -1,294	-2%	-$202K	0.32%	66
2024 Q4	$10.5M	Sell	72,350 -4,315	-6%	-$669K	0.29%	69
2024 Q3	$12.4M	Buy	76,665 +130	+0.2%	+$20.7K	0.35%	55
2024 Q2	$11.2M	Buy	76,535 +1,844	+2%	+$274K	0.35%	55
2024 Q1	$11.8M	Buy	74,691 +3,210	+4%	+$511K	0.39%	52
2023 Q4	$11.2M	Sell	71,481 -2,483	-3%	-$381K	0.45%	49
2023 Q3	$11.5M	Sell	73,964 -4,120	-5%	-$680K	0.53%	46
2023 Q2	$12.9M	Sell	78,084 -1,926	-2%	-$311K	0.58%	40
2023 Q1	$12.4M	Sell	80,010 -16	-0%	-$2.58K	0.53%	42
2022 Q4	$14.1M	Buy	80,026 +2,650	+3%	+$458K	0.68%	34
2022 Q3	$12.6M	Buy	77,376 +7,196	+10%	+$1.22M	0.72%	33
2022 Q2	$12.5M	Buy	70,180 +7,645	+12%	+$1.36M	0.75%	31
2022 Q1	$11.1M	Buy	62,535 +765	+1%	+$130K	0.67%	32
2021 Q4	$10.6M	Buy	61,770 +262	+0.4%	+$42.9K	0.63%	33
2021 Q3	$9.93M	Buy	61,508 +840	+1%	+$143K	0.65%	31
2021 Q2	$9.99M	Buy	60,668 +181	+0.3%	+$30K	0.67%	30
2021 Q1	$9.94M	Buy	60,487 +3,951	+7%	+$639K	0.72%	25
2020 Q4	$8.9M	Buy	56,536 +6,690	+13%	+$987K	0.79%	24
2020 Q3	$7.42M	Buy	49,846 +1,636	+3%	+$242K	0.81%	22
2020 Q2	$6.78M	Buy	48,210 +588	+1%	+$85.7K	0.85%	21
2020 Q1	$6.25M	Buy	47,622 +35,009	+278%	+$4.97M	0.92%	20
2019 Q4	$1.84M	Buy	12,613 +7	+0.1%	+$949	0.23%	54
2019 Q3	$1.63M	Sell	12,606 -39	-0.3%	-$5.14K	0.24%	60
2019 Q2	$1.76M	Sell	12,645 -1,093	-8%	-$151K	0.28%	50
2019 Q1	$1.92M	Sell	13,738 -632	-4%	-$84.7K	0.33%	42
2018 Q4	$1.85M	Sell	14,370 -357	-2%	-$49.8K	0.36%	42
2018 Q3	$2.04M	Sell	14,727 -1,277	-8%	-$170K	0.37%	38
2018 Q2	$1.94M	Buy	16,004 +2,973	+23%	+$371K	0.38%	39
2018 Q1	$1.67M	Buy	13,031 +992	+8%	+$134K	0.38%	41
2017 Q4	$1.68M	Buy	12,039 +2,024	+20%	+$282K	0.43%	35
2017 Q3	$1.3M	Buy	10,015 +9,822	+5,089%	+$1.3M	0.39%	35
2017 Q2	$26K	Hold	193	–	–	0.01%	60
2017 Q1	$24K	Hold	193	–	–	0.01%	59
2016 Q4	$22K	Hold	193	–	–	0.01%	64
2016 Q3	$23K	Hold	193	–	–	0.01%	50
2016 Q2	$23K	Buy	+193	New	+$21.9K	0.02%	65

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Wealthcare Advisory Partners's JNJ Position: Q2 2026 in Review

Wealthcare Advisory Partners reduced its Johnson & Johnson (JNJ) stake by 7.2% in Q2 2026, selling an estimated $687K and leaving 37,978 shares worth $9.65M. The position accounts for 0.18% of the portfolio, ranked #111.

Wealthcare Advisory Partners first reported a position in JNJ in Q2 2016 and has held it in 41 quarters since. The position peaked at $15.6M in Q4 2025. 1,488 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Wealthcare Advisory Partners held 37,978 shares of Johnson & Johnson worth $9.65M as of Q2 2026.
Wealthcare Advisory Partners sold 2,946 Johnson & Johnson shares in Q2 2026, an estimated $687K.
Johnson & Johnson made up 0.18% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #111 holding.
Wealthcare Advisory Partners first reported a position in Johnson & Johnson in Q2 2016 and has held it in 41 quarters since.
Wealthcare Advisory Partners's Johnson & Johnson position peaked at $15.6M in Q4 2025.
1,488 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.